clinical trial · NCT05932303
A Study to Assess the Effect of Multiple Doses of Itraconazole, Gemfibrozil, or Carbamazepine on BMS-986278 in Healthy Participants
Bristol-Myers Squibb·phase1·completed·n = 47
Healthy ParticipantsBMS-986278ItraconazoleGemfibrozilCarbamazepine
brief summary
This is a study in healthy participants designed to assess the effect of multiple doses of itraconazole, gemfibrozil, or carbamazepine on the drug levels of a single-dose of BMS-986278.
started
Jul 12, 2023
primary completion
Oct 23, 2023
completion
Oct 23, 2023
last updated
Oct 30, 2023
official title
A Phase 1, 3-arm, Open-label, Sequential Design Study to Investigate the Effect of Multiple Doses of Itraconazole, Gemfibrozil, or Carbamazepine on Single-dose Pharmacokinetics of BMS-986278 in Healthy Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol